Therapeutic Update 2021 Key West is organized by University Learning Systems (ULS). This onsite medical conference will be held from Apr 21 - 23, 2021 at Hyatt Centric Key West Resort & Spa, Key West, Florida, United States of America.

Target Audience:
• Physicians
• Pharmacists 
• Physician Assistants 
• Nurse Practitioners 
• Nurses

Accreditation:
This conference, Therapeutic Update 2021, one of our most endeavored after CE/CME programs, covers the newest drug information, rendering 15 contact hours (1.5 CEU) over three days, 5 hours per day, of live AAFP/ AMA PRA Category 1™, ACPE and pharmacology CE/ CME credit.

Description:
Session 01: Comprehensive Update in Management of Diabetes Mellitus and Obesity Including Role of Bariatric Surgery
Date: Wednesday, 4/21/2021
Check-in: 7:30AM-8:00AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:
• Summarize recommendations from clinical practice guidelines regarding diabetes.
• Discuss clinical evidence and place in therapy for oral diabetes and GLP-1 agonists agents.
• Discuss the growing evidence and role of SGLT2 inhibitors within diabetes and non-diabetes patients.
• Analyze role of bariatric surgery in management of morbid obesity and diabetes.
• Describe complications and medication related changes post bariatric surgery.
• Evaluate and develop medication regimens post-bariatric surgery through case studies.

Session 02: Hot Topics in Infectious Diseases: New Antimicrobials, Penicillin Allergy De-labeling, Shorter Durations of Therapy, and more IV to PO conversion in complicated infections

Date: Thursday, 04/22/2021
Check-in: 7:30AM-8:00AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:
• Review various newer antimicrobials that have been FDA-approved.
• Evaluate these agents critically for use in clinical practice.
• Discuss penicillin allergies including long-term implications.
• Describe process and recent data supporting intervention strategies to de-label patients.
• Describe disease states for which shorter durations of therapy data are growing.
• Review data for which IV to PO conversion is growing for complicated infections.

Session 03: Hot Topics in Ambulatory Care: New Asthma Guidelines, Migraine Prophylaxis including CGRP antagonists, and COVID-19 for the Primary Care Provider
Date: Friday, 04/23/2021
Check-in: 7:30AM-8:00AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:
• Describe new recommendations to recently published asthma guidelines.Discuss changes in asthma medication recommendations.
• Discuss current role of traditional agents for migraine prophylaxis.
• Describe role of newer CGRP antagonists within migraine prophylaxis.
• Review acute effects of COVID-19 on the primary care provider.
• Provide guidance in managing long-term complications of COVID-19 for the primary care provider.

Note: This Conference is also available as Live Stream Webcast

Additional details will be posted as soon as information is available.